{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:06:52Z","timestamp":1788793612332,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin. Auton. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10286-026-01197-1","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:36:30Z","timestamp":1772008590000},"page":"315-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Significant improvement of postural orthostatic tachycardia syndrome (POTS) with semaglutide: a case report"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-2031","authenticated-orcid":false,"given":"Svetlana","family":"Blitshteyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia M.","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB et\u00a0al. (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372. https:\/\/doi.org\/10.1007\/s10286-011-0119-5","journal-title":"Clin Auton Res"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12026-021-09185-5","volume":"69","author":"S Blitshteyn","year":"2021","unstructured":"Blitshteyn S, Whitelaw S (2021) Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res 69:205\u2013211","journal-title":"Immunol Res"},{"key":"1197_CR3","first-page":"698","volume":"11","author":"D Dulal","year":"2025","unstructured":"Dulal D, Maraey A, Elsharnoby H et\u00a0al. (2025) Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome. Eur Heart J 11:698\u2013704","journal-title":"Eur Heart J"},{"key":"1197_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-025-01319-6","volume":"27","author":"K Sheth","year":"2025","unstructured":"Sheth K, Kim S, Porterfield L et\u00a0al. (2025) The expanding scope of GLP-1 receptor agonists: six uses beyond diabetes. Curr Atheroscler Rep 27:76. https:\/\/doi.org\/10.1007\/s11883-025-01319-6","journal-title":"Curr Atheroscler Rep"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","volume":"166","author":"I Salcedo","year":"2012","unstructured":"Salcedo I, Tweedie D, Li Y, Greig NH (2012) Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Br J Pharmacol 166:1586\u20131599","journal-title":"Br J Pharmacol"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s13311-021-01088-5","volume":"18","author":"M Gharagozloo","year":"2021","unstructured":"Gharagozloo M, Smith MD, Sotirchos ES et\u00a0al. (2021) Therapeutic potential of a novel glucagon-like peptide-1 receptor agonist, NLY01, in experimental autoimmune encephalomyelitis. Neurotherapeutics 18:1834\u20131848","journal-title":"Neurotherapeutics"},{"key":"1197_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104615","volume":"152","author":"G Yoon","year":"2020","unstructured":"Yoon G, Kim Y-K, Song J (2020) Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure. Pharmacol Res 152:104615","journal-title":"Pharmacol Res"},{"key":"1197_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010166","volume":"13","author":"S Blitshteyn","year":"2025","unstructured":"Blitshteyn S (2025) Neuroinflammation at the dorsolateral inferior medulla: a possible central nervous system localization for POTS and long COVID. Biomedicines 13:166","journal-title":"Biomedicines"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/j.2040-4603.2021.tb00152.x","volume":"11","author":"H Suarez-Roca","year":"2021","unstructured":"Suarez-Roca H, Mamoun N, Sigurdson MI, Maixner W (2021) Baroreceptor modulation of the cardiovascular system, pain, consciousness, and cognition. Compr Physiol 11:1373\u20131423","journal-title":"Compr Physiol"},{"key":"1197_CR10","volume":"48","author":"LB Weinstock","year":"2025","unstructured":"Weinstock LB, Afrin LB, Reiersen AM et\u00a0al. (2025) Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndrome. Brain Behav Immun 48:101048","journal-title":"Brain Behav Immun"},{"issue":"4","key":"1197_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.amjms.2025.07.006","volume":"370","author":"LB Afrin","year":"2025","unstructured":"Afrin LB, Weinstock LB, Dempsey T et\u00a0al. (2025) Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome. Am J Med Sci 370(4):377\u2013382","journal-title":"Am J Med Sci"},{"key":"1197_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.105430","author":"E Hedge","year":"2025","unstructured":"Hedge E, Grappe S, Vernino S et\u00a0al. (2025) Exacerbation of postural orthostatic tachycardia syndrome with tirzepatide prescribed for weight loss. JACC Case Rep. https:\/\/doi.org\/10.1016\/j.jaccas.2025.105430","journal-title":"JACC Case Rep"},{"key":"1197_CR13","unstructured":"https:\/\/fnih.org\/wp-content\/uploads\/2025\/08\/RECOVER-TLC-Workshop-Agenda-08_22_2025-4.pdf"},{"key":"1197_CR14","unstructured":"National Institutes of Health. The Long COVID Treatment Trial (LOCITT) 2025. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT07128082"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-026-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-026-01197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-026-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:00:09Z","timestamp":1775797209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-026-01197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1007\/s10286-026-01197-1","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors. SS and LL have nothing to disclose. SB received consultant fees from CSL Behring and honoraria for lectures on long COVID and dysautonomia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patient consent was obtained. Institutional Review Board approval was not necessary for this case report of one patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}